Profile
ABVX VRTX VRNA REGN ALNY ARGX
Company Name Abivax S.A. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $7.47B $108.04B $72.68B $68.01B $60.75B $50.28B
Employees 0.07K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Marc M. P. de Garidel Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
ABVX VRTX VRNA REGN ALNY ARGX
Quant Rating Score 2 3 1 4 1 3
Quant Rating Sell Neutral Strong Sell Buy Strong Sell Neutral
Trading
ABVX VRTX VRNA REGN ALNY ARGX
Last Close $98.94 $417.21 $106.91 $652.91 $481.59 $821.97
High 52 $98.89 $516.74 $106.91 $922.79 $491.09 $849.46
Low 52 $5.24 $366.54 $33.93 $482.92 $224.58 $532.27
Price vs. 52 Week High 0.05 % -19.26 % 0 % -29.25 % -1.93 % -3.24 %
Price vs. 52 Week Low 1788.17 % 13.82 % 215.09 % 35.2 % 114.44 % 54.43 %
Total Return
ABVX VRTX VRNA REGN ALNY ARGX
1 Month Return 16.54 % 6.53 % 0.17 % 16.12 % 5.63 % 11.42 %
3 Month Return 39.68 % -11.07 % 1.68 % 17.71 % 41.85 % 37.25 %
6 Month Return 1295.49 % -18.11 % 48.2 % 9.05 % 82.89 % 27.56 %
9 Month Return 1576.95 % -4.83 % 86.77 % -4.42 % 73.76 % 23.48 %
YTD Return 1251.64 % 3.6 % 130.21 % -8.34 % 104.66 % 33.65 %
1 Year Return 843.18 % -12.18 % 212.69 % -29.25 % 71.09 % 48.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.4 % - -
Dividend Paid and Capex Coverage Ration (TTM) -293.27 % 11.09 % -147.93 % 4.25 % -0.43 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
ABVX VRTX VRNA REGN ALNY ARGX
Asset Growth -37.25 % -0.87 %
Gross Profit Growth 135.94 % 10.25 %
Revenue Growth 133.54 % 11.66 %
Revenue 3 Year 7050.56 % 45.6 %
Revenue 5 Year 104155.36 % 163.93 %
Revenue 10 Year 11236.53 % 1632.15 %
EBIT Growth -29.17 % -93.69 %
Net Income Growth -19.29 % -114.8 %
Net Income 3 Yeari Growth Per Share -1.78 % -122.89 %
Net Income 5 Yeari Growth Per Share -11.16 % -145.38 %
Net Income 10 Yeari Growth Per Share -410.21 % 33.84 %
Operating Income Growth -35.81 % -106.08 %
Operating Cash Flow Growth (CFG) -54.06 % -113.93 %
Operating 3 Year CFG 17.27 % -118.65 %
Operating 5 Year CFG -8.35 % -131.3 %
Operating 10 Year CFG -585.58 % 12.43 %
EPS Growth 18.37 % -114.8 %
EPS Diluted Growth 18.37 % -114.97 %
Book Value Per Share -85.86 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -61.63 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -57.82 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -82.41 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 75.54 % 116.42 %
Free Cash Flow Growth -54.29 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ABVX VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM 100 % 86.11 % 95.15 % 85.39 % 83.64 % 65.82 %
Return on Assets TTM -163.31 % 15.13 % -14.17 % 11.4 % -6.99 % 15.06 %
Return on Equity TTM 5077.65 % 22.14 % -38.66 % 15.31 % -274.21 % 18.96 %
Return on Capital Employed TTM -2731.94 % 19.72 % -10.74 % 10.32 % -5.52 % 5.04 %
Net Income Per EBT TTM 98 % 83.16 % 111.3 % 88.98 % 84.06 % 237.3 %
EBT Per Ebit TTM 100.12 % 111.48 % 130.22 % 139.5 % 210.66 % 147.38 %
EBIT Per Revenue TTM -3306.18 % 34.36 % -25.27 % 25.89 % -7.32 % 13.47 %
Cash Flow To Debt Ratio TTM -138.75 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Receivables Turnover TTM - 6.03 2.55 2.51 4.34 1.91
Payables Turnover TTM 0.01 3.59 3.13 2.3 3.93 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 5.62 2.26
Fixed Asset Turnover TTM 278.97 % 431.08 % 8642.22 % 284.82 % 355.68 % 5009.77 %
Asset Turnover TTM 5.03 % 47.51 % 38.7 % 35.47 % 53.92 % 31.97 %
Operating Cash Flow Per Share TTM -2.16 14.98 -0.85 48.94 -0.12 5.67
Free Cash Flow Per Share TTM -2.17 13.63 -0.85 40.09 -0.4 5.58
Cash Per Share TTM 96.11 % 2486.48 % 511.44 % 8148.65 % 2203.63 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -2273.9 % 33.68 % -32.7 % 35.59 % -0.63 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.34 % 90.99 % 100.75 % 81.92 % 335.21 % 98.47 %
Cash Flow Coverage Ratios TTM -138.75 % 251.83 % -29.66 % 187.43 % -1.2 % 932.29 %
Price To Free Cash Flows Ratio TTM -49.78 30.87 -995.27 16.37 -1166.22 132.81
Price To Operating Cash Flows Ratio TTM -40.7 28.12 -126.33 13.34 -3867.41 151.69
Price Cash Flow Ratio TTM -40.7 28.12 -126.33 13.34 -3867.41 151.69
Income Statement (TTM)
ABVX VRTX VRNA REGN ALNY ARGX
Revenue $0.01B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0.01B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.17B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.18B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -2.8 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
ABVX VRTX VRNA REGN ALNY ARGX
Long Term Debt $0.05B $1.66B $0.12B $2.7B $1.25B $0.03B
Total Liabilities $0.16B $6.12B $0.27B $8.41B $4.17B $0.7B
Total Equity $0.04B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0B $6.65B $0.02B $15.42B $1.73B $1.93B
Total Debt $0.1B $1.75B $0.12B $2.7B $1.3B $0.04B
Total Assets $0.21B $22.53B $0.47B $37.76B $4.24B $6.2B
Cash Flow Statement (TTM)
ABVX VRTX VRNA REGN ALNY ARGX
Net Income $-0.18B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.15B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 33.05
AARD Aardvark Therapeutics, Inc. Common Stock 10.8826
ABCL AbCellera Biologics Inc. 5.4888
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.2869
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.2776
ABPWW 0.0143
ABSI Absci Corporation 4.235
ABUS Arbutus Biopharma Corporation 4.875
ABVC ABVC BioPharma, Inc. 2.85
ACAD ACADIA Pharmaceuticals Inc. 22.83
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7963
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.045
ACIU AC Immune SA 3.625
ACLX Arcellx, Inc. 87.755
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 54.56
BOUT Innovator IBD Breakout Opportunities ETF 2.56 38.55
SPEU SPDR Portfolio Europe ETF 0.001349 50.36
MMSC First Trust Multi-Manager Small Cap Opportunities ETF 0.000001 24.55
PINK Simplify Health Care ETF 1.92606 33.47
DBXW.DE Xtrackers MSCI World Swap UCITS ETF 0.249958 120.04
XWEH.F Xtrackers MSCI World Swap UCITS ETF 0.249958 32.014
XWD1.F Xtrackers MSCI World Swap UCITS ETF 0.249958 16.5615
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 326.6
XMWD.L Xtrackers MSCI World Swap UCITS ETF 0.249958 138.827
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 28778.2
XWEH.DE Xtrackers MSCI World Swap UCITS ETF 0.249958 47.482
Unlock